» Articles » PMID: 28739909

Solution Structure of the TLR Adaptor MAL/TIRAP Reveals an Intact BB Loop and Supports MAL Cys91 Glutathionylation for Signaling

Overview
Specialty Science
Date 2017 Jul 26
PMID 28739909
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

MyD88 adaptor-like (MAL) is a critical protein in innate immunity, involved in signaling by several Toll-like receptors (TLRs), key pattern recognition receptors (PRRs). Crystal structures of MAL revealed a nontypical Toll/interleukin-1 receptor (TIR)-domain fold stabilized by two disulfide bridges. We therefore undertook a structural and functional analysis of the role of reactive cysteine residues in the protein. Under reducing conditions, the cysteines do not form disulfides, but under oxidizing conditions they are highly amenable to modification. The solution structure of the reduced form of the MAL TIR domain, determined by NMR spectroscopy, reveals a remarkable structural rearrangement compared with the disulfide-bonded structure, which includes the relocation of a β-strand and repositioning of the functionally important "BB-loop" region to a location more typical for TIR domains. Redox measurements by NMR further reveal that C91 has the highest redox potential of all cysteines in MAL. Indeed, mass spectrometry revealed that C91 undergoes glutathionylation in macrophages activated with the TLR4 ligand lipopolysaccharide (LPS). The C91A mutation limits MAL glutathionylation and acts as a dominant negative, blocking the interaction of MAL with its downstream target MyD88. The H92P mutation mimics the dominant-negative effects of the C91A mutation, presumably by preventing C91 glutathionylation. The MAL C91A and H92P mutants also display diminished degradation and interaction with interleukin-1 receptor-associated kinase 4 (IRAK4). We conclude that in the cell, MAL is not disulfide-bonded and requires glutathionylation of C91 for signaling.

Citing Articles

Structural characterization of TIR-domain signalosomes through a combination of structural biology approaches.

Bhatt A, Mishra B, Gu W, Sorbello M, Xu H, Ve T IUCrJ. 2024; 11(Pt 5):695-707.

PMID: 39190506 PMC: 11364022. DOI: 10.1107/S2052252524007693.


o-Vanillin binds covalently to MAL/TIRAP Lys-210 but independently inhibits TLR2.

Rahaman M, Thygesen S, Maxwell M, Kim H, Mudai P, Nanson J J Enzyme Inhib Med Chem. 2024; 39(1):2313055.

PMID: 38416868 PMC: 10903754. DOI: 10.1080/14756366.2024.2313055.


Human and Bacterial Toll-Interleukin Receptor Domains Exhibit Distinct Dynamic Features and Functions.

Lee E, Redzic J, Nemkov T, Saviola A, Dzieciatkowska M, Hansen K Molecules. 2022; 27(14).

PMID: 35889366 PMC: 9318647. DOI: 10.3390/molecules27144494.


Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn ions.

Lushpa V, Goncharuk M, Lin C, Zalevsky A, Talyzina I, Luginina A Commun Biol. 2021; 4(1):1003.

PMID: 34429510 PMC: 8385042. DOI: 10.1038/s42003-021-02532-0.


TIRAP in the Mechanism of Inflammation.

Rajpoot S, Wary K, Ibbott R, Liu D, Saqib U, Thurston T Front Immunol. 2021; 12:697588.

PMID: 34305934 PMC: 8297548. DOI: 10.3389/fimmu.2021.697588.


References
1.
Stottmeier B, Dick T . Redox sensitivity of the MyD88 immune signaling adapter. Free Radic Biol Med. 2016; 101:93-101. DOI: 10.1016/j.freeradbiomed.2016.10.004. View

2.
Motshwene P, Moncrieffe M, Grossmann J, Kao C, Ayaluru M, Sandercock A . An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem. 2009; 284(37):25404-11. PMC: 2757241. DOI: 10.1074/jbc.M109.022392. View

3.
Liao B, Hsieh C, Lin Y, Wung B . The glutaredoxin/glutathione system modulates NF-kappaB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicol Sci. 2010; 116(1):151-63. DOI: 10.1093/toxsci/kfq098. View

4.
Tyler R, Sreenath H, Singh S, Aceti D, Bingman C, Markley J . Auto-induction medium for the production of [U-15N]- and [U-13C, U-15N]-labeled proteins for NMR screening and structure determination. Protein Expr Purif. 2005; 40(2):268-78. DOI: 10.1016/j.pep.2004.12.024. View

5.
Jefferies C, Doyle S, Brunner C, Dunne A, Brint E, Wietek C . Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem. 2003; 278(28):26258-64. DOI: 10.1074/jbc.M301484200. View